Cargando…

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

INTRODUCTION: The immune mechanisms supporting partial protection from reinfection and disease by the respiratory syncytial virus (RSV) have not been fully characterized. In older adults, symptoms are typically mild but can be serious in patients with comorbidities when the infection extends to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salaun, Bruno, De Smedt, Jonathan, Vernhes, Charlotte, Moureau, Annick, Öner, Deniz, Bastian, Arangassery Rosemary, Janssens, Michel, Balla-Jhagjhoorsingh, Sunita, Aerssens, Jeroen, Lambert, Christophe, Coenen, Samuel, Butler, Christopher C., Drysdale, Simon B., Wildenbeest, Joanne G., Pollard, Andrew J., Openshaw, Peter J. M., Bont, Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627235/ https://www.ncbi.nlm.nih.gov/pubmed/37936699 http://dx.doi.org/10.3389/fimmu.2023.1260146

Ejemplares similares

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
por: Lin, Gu-Lung, et al.
Publicado: (2021)

Publisher Correction: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
por: Lin, Gu-Lung, et al.
Publicado: (2021)

World Health Organization Influenza-Like Illness Underestimates the Burden of Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults
por: Korsten, Koos, et al.
Publicado: (2021)

Performance Assessment of a Rapid Molecular Respiratory Syncytial Virus Point-of-Care Test: A Prospective Community Study in Older Adults
por: Zuurbier, Roy P, et al.
Publicado: (2022)

International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures
por: Billard, Marie‐Noëlle, et al.
Publicado: (2022)

The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
por: Wildenbeest, Joanne G, et al.
Publicado: (2023)

Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained
por: Balla-Jhagjhoorsingh, Sunita S., et al.
Publicado: (2011)

The N276 Glycosylation Site Is Required for HIV-1 Neutralization by the CD4 Binding Site Specific HJ16 Monoclonal Antibody
por: Balla-Jhagjhoorsingh, Sunita S., et al.
Publicado: (2013)

Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases
por: Carande, Elliott J., et al.
Publicado: (2016)

Contact With Young Children Increases the Risk of Respiratory Infection in Older Adults in Europe—the RESCEU Study
por: Korsten, Koos, et al.
Publicado: (2021)

Potential therapeutic implications of new insights into respiratory syncytial virus disease
por: Openshaw, Peter JM
Publicado: (2002)

The Respiratory Mucosa: Front and Center in Respiratory Syncytial Virus Disease
por: Thwaites, Ryan S., et al.
Publicado: (2019)

Fail-Fast in Respiratory Syncytial Virus Vaccine Development
por: Besteman, Sjanna B., et al.
Publicado: (2019)

Respiratory syncytial virus: diagnosis, prevention and management
por: Barr, Rachael, et al.
Publicado: (2019)

Mucosal Immune Responses to Respiratory Syncytial Virus
por: Barnes, Megan V. C., et al.
Publicado: (2022)

The disease burden of respiratory syncytial virus in Infants
por: Munro, Alasdair P.S., et al.
Publicado: (2023)

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
por: Sadoff, Jerald, et al.
Publicado: (2021)

Live-attenuated Respiratory Syncytial Virus Vaccines: Time for the Next Step
por: Billard, Marie-Noëlle, et al.
Publicado: (2021)

Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months
por: Stuart, Arabella S V, et al.
Publicado: (2022)

A New Role for CXCL4 in Respiratory Syncytial Virus Disease
por: Wiseman, Dexter J., et al.
Publicado: (2020)

Respiratory syncytial virus (RSV): over 60 years of research but still so many unanswered questions
por: Drysdale, Simon B., et al.
Publicado: (2023)

Respiratory syncytial virus (RSV) disease – new data needed to guide future policy
por: Campbell, Harry, et al.
Publicado: (2015)

Neutrophils in respiratory syncytial virus infection: A target for asthma prevention
por: Geerdink, Ruben J., et al.
Publicado: (2015)

A41 Deep sequencing of respiratory syncytial virus links viral diversity to disease severity
por: Nauwelaers, Inne, et al.
Publicado: (2019)

Airway response to respiratory syncytial virus has incidental antibacterial effects
por: Sande, Charles J., et al.
Publicado: (2019)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
por: Gastaldi, Andrea, et al.
Publicado: (2021)

Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology
por: Walzl, Gerhard, et al.
Publicado: (2000)

Author Correction: Airway response to respiratory syncytial virus has incidental antibacterial effects
por: Sande, Charles J., et al.
Publicado: (2019)

P04-52 LB. The importance of well-defined HIV-1 neutralization assays
por: Balla-Jhagjhoorsingh, SS, et al.
Publicado: (2009)

2775. Safety and Immunogenicity of a Seasonal Influenza Vaccine and Ad26.RSV.preF Vaccine With and Without Co-Administration: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study in Adults Aged ≥ 60 Years
por: Comeaux, Christy, et al.
Publicado: (2019)

Delayed Sequelae of Neonatal Respiratory Syncytial Virus Infection Are Dependent on Cells of the Innate Immune System
por: Harker, James A., et al.
Publicado: (2014)

Respiratory syncytial virus hospitalization and mortality: Systematic review and meta‐analysis
por: Stein, Renato T., et al.
Publicado: (2016)

Respiratory syncytial virus and influenza virus infection in adult primary care patients: Association of age with prevalence, diagnostic features and illness course
por: Bruyndonckx, Robin, et al.
Publicado: (2020)

Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US
por: Zheng, Zhe, et al.
Publicado: (2021)

Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
por: Rozenbaum, Mark H., et al.
Publicado: (2023)

Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season
por: Gandhi-Banga, Sonja, et al.
Publicado: (2019)

Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt
por: De Luca, Daniele, et al.
Publicado: (2023)

The Association between Weather Conditions and Admissions to the Paediatric Intensive Care Unit for Respiratory Syncytial Virus Bronchiolitis
por: Linssen, Rosalie S., et al.
Publicado: (2021)

Systemic Signature of the Lung Response to Respiratory Syncytial Virus Infection
por: Pennings, Jeroen L. A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kqkjffg19dqiohn8p0qbasmeug